Products Details

Product Description

– PSI-7409 is the active 5′-triphosphate metabolite of Sofosbuvir (PSI-7977). Sofosbuvir (PSI-7977) is a selective and highly active nucleotide analog inhibitor of HCV.

Web ID

– HY-15745

Storage Temperature

– -20°C, 3 years (Powder)

Shipping

– Blue Ice

Applications

– Cancer-programmed cell death

Molecular Formula

– C10H16FN2O14P3

Citations

– Antiviral Res. 2020 Mar;175:104708.|Biochem Biophys Res Commun. 2022 Dec 8;641:50-56.|Cell. 2022 Nov 10;185(23):4347-4360.e17.|J Virol Methods. 2021 Sep 14;298:114283.|Microbiol Spectr. 2022 Aug 18;e0272922.|Asian J Pharm Sci. 21 October 2021.

References

– [1]Lam AM, et al. PSI-7851, a pronucleotide of beta-D-2′-deoxy-2′-fluoro-2′-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication. Antimicrob Agents Chemother. 2010 Aug;54(8):3187-96.|[2]Murakami E, et al. Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977.

CAS Number

– 1015073-42-3

Molecular Weight

– 500.16

Compound Purity

– 98.03

SMILES

– O[C@@H]([C@@](C)(F)[C@H](N1C(NC(C=C1)=O)=O)O2)[C@H]2COP(O)(OP(OP(O)(O)=O)(O)=O)=O

Clinical Information

– No Development Reported

Research Area

– Cancer

Solubility

– DMF : 10 mg/mL (ultrasonic;warming;heat to 80°C)|DMSO : 1 mg/mL (ultrasonic)|H2O : 50 mg/mL (ultrasonic)

Target

– HCV

Pathway

– Anti-infection

Product type

– Reference compound

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

=

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.

=